Page last updated: 2024-08-18

thiophenes and Hypertrophy

thiophenes has been researched along with Hypertrophy in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Flynn, B; Hua, Y; Huang, L; Kaye, D; Liew, D; Magaye, RR; Reid, C; Savira, F; Wang, BH; Xiong, X1
Cross, DM; Derzi, M; Horsley, E; Owen, K; Stavros, FL1
Drexler, W; Findl, O; Heinzl, H; Kiss, B; Petternel, V; Wirtitsch, MG1
Block, N; Brock, TA; Chen, SJ; Chen, YF; Dixon, RA; Munsch, CL; Sherwood, SJ; Tilton, RG; Wu, C1
Herndon, RM1

Trials

1 trial(s) available for thiophenes and Hypertrophy

ArticleYear
Short-term effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2003, Volume: 121, Issue:5

    Topics: Administration, Topical; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Cell Count; Cornea; Corneal Diseases; Cross-Over Studies; Double-Blind Method; Endothelium, Corneal; Female; Humans; Hypertrophy; Interferometry; Light; Male; Middle Aged; Sulfonamides; Thiophenes

2003

Other Studies

4 other study(ies) available for thiophenes and Hypertrophy

ArticleYear
Exogenous dihydrosphingosine 1 phosphate mediates collagen synthesis in cardiac fibroblasts through JAK/STAT signalling and regulation of TIMP1.
    Cellular signalling, 2020, Volume: 72

    Topics: Animals; Animals, Newborn; Biomarkers; Cell Differentiation; Collagen; Fibroblasts; Gene Expression Regulation; Hypertrophy; Janus Kinases; Lysophospholipids; Matrix Metalloproteinase 2; Models, Biological; Myocardium; Myocytes, Cardiac; Oxadiazoles; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Smad2 Protein; Sphingosine; STAT Transcription Factors; Thiophenes; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta

2020
An overview of the preclinical toxicity and potential carcinogenicity of sitaxentan (ThelinĀ®), a potent endothelin receptor antagonist developed for pulmonary arterial hypertension.
    Regulatory toxicology and pharmacology : RTP, 2012, Volume: 64, Issue:1

    Topics: Alkaline Phosphatase; Animals; Antihypertensive Agents; Blood Coagulation; Carcinogenicity Tests; Carcinogens; Chemical and Drug Induced Liver Injury, Chronic; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endothelin Receptor Antagonists; Erythrocyte Indices; Female; Hypertension, Pulmonary; Hypertrophy; Isoxazoles; Liver; Liver Function Tests; Male; Mice; Mice, Inbred Strains; Organ Size; Rats; Rats, Sprague-Dawley; Risk Assessment; Species Specificity; Thiophenes

2012
Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
    Pulmonary pharmacology & therapeutics, 2000, Volume: 13, Issue:2

    Topics: Animals; Cardiomegaly; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypertrophy; Hypoxia; Isoxazoles; Male; Monocrotaline; Oxygen; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Thiophenes; Vasoconstriction; Weight Gain

2000
Thiophen induced granule cell necrosis in the rat cerebellum. An electron microscopic study.
    Experimental brain research, 1968, Volume: 6, Issue:1

    Topics: Animals; Cerebellum; Cytoplasmic Granules; Dendrites; Hypertrophy; Microscopy; Microscopy, Electron; Necrosis; Nerve Degeneration; Neuroglia; Neurons; Purkinje Cells; Rats; Synapses; Thiophenes

1968